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Chronic pulmonary infections caused by non-tuberculous mycobacteria of the
Mycobacterium abscessus complex (MABSC) are emerging as a global health problem
and pose a threat to susceptible individuals with structural lung disease such as cystic
fibrosis. The molecular mechanisms underlying the pathogenicity and intrinsic resistance
of MABSC to antibiotics remain largely unknown. The involvement of Msp-type porins
in the virulence and biocide resistance of some rapidly growing non-tuberculous
mycobacteria and the finding of deletions and rearrangements in the porin genes of
serially collected MABSC isolates from cystic fibrosis patients prompted us to investigate
the contribution of these major surface proteins to MABSC infection. Inactivation by
allelic replacement of the each of the two Msp-type porin genes of M. abscessus subsp.
massiliense CIP108297, mmpA and mmpB, led to a marked increase in the virulence
and pathogenicity of both mutants in murine macrophages and infected mice. Neither
of the mutants were found to be significantly more resistant to antibiotics. These results
suggest that adaptation to the host environment rather than antibiotic pressure is the
key driver of the emergence of porin mutants during infection.
Keywords: Mycobacterium, abscessus, porin, virulence, antibiotic resistance
INTRODUCTION
Two groups of organisms account for 70–95% of the pulmonary non-tuberculous mycobacteria
(NTM) infections worldwide: The Mycobacterium avium complex (MAC) and the Mycobacterium
abscessus complex (MABSC) (Park and Olivier, 2015). While MAC is still, overall, the most
common cause of NTM infections in the United States (accounting for over 70% of NTM
pulmonary infections), over the last 10 years, rapidly growing NTM of the M. abscessus complex
(MABSC) [including M. abscessus subsp. abscessus (Mabs), M. abscessus subsp. massiliense [Mmas]
and M. abscessus subsp. bolletii] have emerged as important human pathogens globally, causing an
increasing number of pulmonary infections among patients with structural lung disease such as
chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis (CF) (Floto and Haworth,
2015; Park and Olivier, 2015; Martiniano et al., 2019; Johansen et al., 2020). Detailed epidemiology
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and population-level whole genome sequencing studies have
indicated that dominant circulating clones of Mabs and Mmas
have recently emerged and are now present on every continent
(Shang et al., 2011; Aitken et al., 2012; Bryant et al., 2013,
2016; Davidson et al., 2013; Tettelin et al., 2014). These clones
are associated with worse clinical outcomes, have increased
ability to infect and survive within macrophages, and cause
more severe infections in mouse models (Shang et al., 2011;
Bryant et al., 2016).
Despite recent advances in the genomics and genetics of
MABSC organisms and the availability of a growing number
of cellular and animal models of NTM infection (Medjahed
and Reyrat, 2009; Ripoll et al., 2009; Bryant et al., 2016;
Bernut et al., 2017), the molecular mechanisms underlying the
intrinsic antibiotic resistance/tolerance, virulence and adaptation
of MABSC species to becoming chronic pathogens of the
lung are still poorly understood. Previous studies from our
laboratory and others have established the important role played
by outer membrane porins in the virulence and biocide resistance
of rapidly growing mycobacteria including M. smegmatis and
M. chelonae (Stephan et al., 2004; Sharbati-Tehrani et al.,
2005; Danilchanka et al., 2008; Fabrino et al., 2009; Svetlikova
et al., 2009; Purdy et al., 2009; Frenzel et al., 2011; Rodrigues
et al., 2011). Msp-type porins represent the main general
diffusion pathway for small hydrophilic molecules across the
outer membrane of rapidly growing mycobacteria (Niederweis,
2003). Not only does their presence at the cell surface
increase the permeability and susceptibility of M. smegmatis
and M. chelonae to antibiotics and disinfectants (Stephan et al.,
2004; Danilchanka et al., 2008; Svetlikova et al., 2009; Frenzel
et al., 2011; Rodrigues et al., 2011), it was also found to impact
the survival of M. smegmatis and that of an M. tuberculosis
mspA-expressing strain inside phagocytic cells by increasing
the susceptibility of the bacilli to killing by reactive nitrogen
intermediates, ubiquitin-derived antimicrobial peptides and
lysosomal enzymes (Sharbati-Tehrani et al., 2005; Fabrino et al.,
2009; Purdy et al., 2009).
The reported involvement of porins in the virulence
phenotype and biocide resistance of some rapidly growing
mycobacteria, combined with the finding of deletions and
rearrangements in the porin genes of serially collected Mabs
and Mmas isolates from CF patients and genetic polymorphisms
affecting the porin locus of MABSC isolates globally, led us
to investigate the potential roles played by Msp-type porins in
the adaptation of MABSC to the host and to antibiotic and
disinfectant exposure.
MATERIALS AND METHODS
Bacterial Strains and Culture Media
Escherichia coli DH5α, the strain used for cloning, was grown
in LB Lennox (BD, Difco) medium at 37◦C. M. abscessus
subsp. massiliense (Mmas) CIP108297, a clinical isolate recovered
from the sputum and bronchoalveolar fluid of a patient
with hemoptoic pneumonia (Adekambi et al., 2004) was
grown at 37◦C in Middlebrook 7H9-OADC broth (BD, Difco)
supplemented with 0.05% Tween 80, Mueller-Hinton II broth
(BD, Difco), minimal Glycerol-Alanine-Salt (GAS) medium
supplemented with 0.05% tyloxapol (pH 6.6), or on Middlebrook
7H11-OADC agar (BD, Difco). Kanamycin (Kan), hygromycin
(Hyg) and streptomycin (Str) were added to final concentrations
of 400, 1,000, and 200 µg/ml, respectively.
Generation of Porin Knock-Out Mutants
Recombineering was used to inactivate the
MMCCUG48898_0905 (herein renamed mmpA) and
MMCCUG48898_0906 (herein renamed mmpB) genes of
Mmas CIP108297 by allelic replacement. To this end, the Gp60
and Gp61 recombineering proteins from mycobacteriophage
Che9c were expressed from the replicative plasmid pJV53-XylE
under control of an acetamide-inducible promoter as described
(van Kessel and Hatfull, 2007; van Kessel et al., 2008; Calado
Nogueira de Moura et al., 2014). Acetamide-induced Mmas
CIP108297 harboring pJV53-XylE were electro-transformed
with linear allelic exchange substrates encompassing the mmpA
and mmpB loci and double-crossover mutants were isolated
on Str-containing medium. The linear allelic substrate used
to delete the mmpA locus was generated by bracketing the
streptomycin-resistance cassette from pHP45 with 571–500 bp
of upstream and downstream DNA sequence flanking the
internal XmnI restriction site of mmpA, respectively. The linear
allelic substrate used to delete the mmpB locus was generated
by similarly bracketing the streptomycin-resistance cassette
with 565–357 bp of upstream and downstream DNA sequence
immediately flanking the internal XmnI restriction site of
mmpB. The linear allelic substrate used to try and delete both
porin genes simultaneously was generated by bracketing the
streptomycin-resistance cassette with 571 bp of DNA sequence
located upstream the XmnI site of mmpA and 357 bp of DNA
sequence downstream the XmnI site of mmpB.
pOMK-mmpA, pOMK-mmpB, and pOMK-mmpAB, the
replicative plasmids used for the complementation of the knock-
out mutants, were constructed by cloning mmpA, mmpB or
a 2.1 kb region encompassing both genes in the multicopy
plasmid pOMK (Calado Nogueira de Moura et al., 2014).
The mmpA and mmpB genes are expressed from their own
promoter in the complementation constructs. The sequences of
the primers used to generate the different constructs are provided
in Supplementary Table 1.
Phenotypic Assays
The susceptibility of Mmas to commercial glutaraldehyde
(GTA) in suspension tests, MIC determinations and [U-
14C]-glucose (5 mCi/mmol; American Radiolabeled Chemicals)
uptake experiments were performed as described in Calado
Nogueira de Moura et al., 2014. For in vitro NO susceptibility
studies, Mmas strains (approximately 2 × 107 cells) grown
in 7H9-OADC medium were resuspended in 1 ml phosphate
buffer (pH 7.4) and exposed to 10 mM Spermine NONOate
(Cayman Chemical) for 4–24 h at 25◦C at which time point
viable CFUs were enumerated by plating serial dilutions of the
cell suspensions on 7H11-OADC agar.
Frontiers in Microbiology | www.frontiersin.org 2 July 2021 | Volume 12 | Article 706207
fmicb-12-706207 July 9, 2021 Time: 16:42 # 3
de Moura et al. Mycobacterium abscessus Porin Mutants
Immunoblot Analysis of Outer Membrane
Porins
Porin extraction and immunoblot analysis using anti-MspA
antibodies (Stahl et al., 2001) was carried out as described
previously (Calado Nogueira de Moura et al., 2014).
RNA Preparation, Reverse Transcription
and qRT-PCR
Mmas RNA was extracted from 5-ml cultures grown to
an OD600 of 0.2 using the Direct-zol RNA Miniprep kit
(Zymo Research) per the manufacturer’s instructions. Reverse
transcription reactions were carried out using the Superscript
V kit (Invitrogen), and qRT-PCRs were run using the SsoFast
Evagreen Supermix kit (Bio-Rad) as per the manufacturers’
protocols and analyzed on a CFX96 real-time PCR machine
(Biorad). PCR conditions: 98◦C (2 min; enzyme activation),
followed by 35 cycles of 98◦C (5 sec; denaturation) and
55◦C (5 sec; annealing/extension). Mock reactions (no reverse
transcription) were done on each RNA sample to rule out DNA
contamination. The target cDNA was normalized internally to
the sigA cDNA levels in the same sample. The primer sequences
are provided in Supplementary Table 1.
Genome Dataset, Mapping, de novo
Assembly and Annotation
A previously published global collection of MABSC isolates,
consisting of 526 isolates associated with pulmonary infections
and 189 isolates collected from nine separate outbreak locations
in Brazil, was used in this study (Bryant et al., 2016; Everall
et al., 2017). These isolates were further supplemented by an
additional 665 longitudinal isolates associated with 190 patients
with Cystic Fibrosis (CF) (Bryant et al., 2021). The Illumina
Hiseq 2,500 paired end raw reads of all the isolates were mapped
using BWA-MEM v0.7.12 to the reference genome Mabs ATCC
19977 (Li. 2013). Assemblies for all the isolates were generated
and optimized using Velvet and Velvet optimizer, respectively
(Zerbino and Birney, 2008). The final draft assemblies were
annotated using PROKKA (Seemann, 2014).
Phylogenetic Analysis
An alignment was produced from the mapping of 526 isolates
associated with pulmonary infections and 188 isolates associated
with the post-surgical wound infection epidemic in Brazil to
the Mabs ATCC 19977 reference genome, using SAMtools
v1.2 and BCFtools v4.2, with parameters previously described
(Li et al., 2009; Harris et al., 2010). Briefly, a variant was
inferred if the following criteria were met: A mapping quality
of 20, a base call quality of 50, eight reads supporting the
alternative allele and three reads supporting the alternative allele
on either strand. Heterozygous SNP sites were masked. An
alignment of the variable positions was created using SNP-sites
and used to produce a maximum likelihood phylogeny with
RAxML (Stamatakis, 2014; Page et al., 2016). Hundred bootstrap
replicates were performed.
Detection of Msp-Like Porin Gene
Homologs in MABSC Genomes
A local tblastx search was performed to detect homologs
of msp-like porin genes in the MABSC genomes. A local
database was made using the nucleotide sequences of mmpA
(MAB_1080), mmpB (MAB_1081) and the possible mmpC
homolog (MAB_2800). The assemblies of 1,382 MABSC isolates
were queried against this database with msp-like porin gene
homologs predicted if a match had a percent identity greater than
50%, E-value < 0.05 and a match length greater than or equal
to 50% of the length of the reference gene of mmpA (672 bps),
mmpB (669 bps) and mmpC (741 bps).
Analysis of the mspA/mspB Porin Locus
Configuration; Identification of the
Fusion Position, and Identification of
Loss of Function Mutations in mmpA and
mmpB
The coverage over the porin locus containing the mmpA and
mmpB genes was determined for each isolate using SAMtools
v1.3, with a mapping quality threshold of 20 (probability mapped
to correct location 99%), base call quality of 30 (base call is
99.9% accurate) (Li et al., 2009). Presence of both msp-like
porin genes at this locus was determined by an average depth
of coverage greater than eight in the 436 bp intergenic region
between mmpA and mmpB and an average depth of coverage
greater than eight over both mmpA and mmpB. Deletion of both
mmp-like porin genes at this locus was determined by the absence
of coverage (average of less than eight reads mapped) in the
intergenic region between mmpA and mmpB and a reduction in
depth of coverage greater than 20 between the 1,000 bp region
upstream of the start of the porin loci and the 94 bp signal
peptide region of mmpA. The presence of a single mmp-like
porin gene at this locus was determined by absence of coverage
in the intergenic region between mmpA and mmpB (average of
less than eight reads mapped) and no reduction in depth of
coverage greater than 20 between the 1,000 bp flanking region
upstream of the porin loci and the 94 bp signal peptide region
of mmpA. The figures were made using easyfig (Sullivan et al.,
2011). A two tailed Fisher’s exact test was performed to determine
if there was an association between the mmpA and mmpB porin
locus configuration and isolates classified as clustered and more
virulent and those classified as unclustered by Bryant et al. (2016).
Where only one mmp-like porin gene was present at the
mmpA/mmpB porin locus, an alignment of the nucleotide
sequence of this gene, and the reference mmpA (MAB_1080)
and mmpB (MAB_1081) genes was created using muscle v3.8.31
(Edgar, 2004). The position at which the recombination event
occurred was predicted based on where the mmp-like porin gene
of the isolate with one mmp-like porin gene at the mmpA/mmpB
porin locus changed from being more similar to mmpA to being
more similar to mmpB.
The raw reads of the 1,382 isolates were further mapped to
the Mabs ATCC 19977 mmpA/mmpB porin locus using BWA-
MEM v0.7.12 (Li, 2013). Variants were called using SAMtools
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v1.2 and BCFtools v4.2 with the following parameters (Li et al.,
2009): A base call quality of 30 and mapping quality of 20, a
minimum of eight reads supporting the alternative base, with
a minimum of three reads supporting the alternative base on
each strand. Variants, including Indels, were only determined for
isolates predicted to encode both mmpA and mmpB at this locus.
Mice
Specific-pathogen-free female SCID and GMCSF knock-out
mice, from 6 to 8 weeks old, were purchased from the Jackson
Laboratories, Bar Harbor, Maine. Mice were maintained in
the Biosafety Level III animal laboratory at Colorado State
University, and were given sterile water, mouse chow, bedding,
and enrichment for the duration of the experiments. The specific
pathogen-free nature of the mouse colonies was demonstrated
by testing sentinel animals. All experimental protocols were
approved by the Animal Care and Usage Committee of




Bone marrow-derived macrophages (BMDM) from GMCSF and
SCID knock-out mice were infected with mycobacteria at a
one bacterium per one macrophage ratio and, 2 h later, the
monolayers were washed to remove extracellular bacilli. The
numbers of intracellular mycobacteria were measured by plating.
Briefly, monolayers were washed at each time point to remove
extracellular bacilli and 1 ml double-distilled H2O containing
0.05% Tween 80 was added to monolayers and incubated for
10 min to lyse macrophages. After passing through a 26-gauge
needle five times, the lysates were serially diluted and plated
onto 7H11-OADC agar. Monolayers that weren’t lysed were
replenished with fresh medium as previously described (Shang
et al., 2011; Obregon-Henao et al., 2015). BMDM viability
was assayed by trypan blue exclusion and determined by flow
cytometry using BD Viability Counting Beads, as described by the
manufacturer (BD PharMingen, San Jose, CA United States) cell
viability-staining methods.
SCID Mice Infection
SCID mice were challenged with WT, mutant and complemented
mutant strains using an infection calibrated to deliver 1.0 × 106
bacilli per animal. At days 1 and 15 following infection, bacterial
loads in the lungs, spleen and liver, and lung histology were
determined. Bacterial counts were determined by plating serial
dilutions of organ homogenates on 7H11-OADC agar and
counting colony-forming units after 5–10 days of incubation at
30◦C. A total of five animals were infected for each time point.
Histological Analysis
The whole lung from each mouse was fixed with 10% formalin
in phosphate buffered saline (PBS). Tissue sections were stained
using hematoxylin and eosin and acid-fast stain as previously
reported (Bryant et al., 2016).
Statistical Analysis
Data are presented using the mean values from five mice
per group and from values from replicate samples and
triplicate macrophage infection assays. The unpaired Student’s
t-test test was used to assess statistical significance between
infection groups.
RESULTS
Msp-Like Porin Genes in the Genomes of
Reference MABSC Isolates
The reference strains Mmas CIP108297 (alias CCUG 48898) and
Mabs ATCC 19977 harbor two clustered Msp-like porin genes
annotated as MMCCUG48898_0905/MMCCUG48898_0906 and
MAB_1080/MAB_1081, respectively (Ripoll et al., 2009; Tettelin
et al., 2012). We renamed the two Mmas genes mmpA and
mmpB for Mycobacterium abscessus subsp. massiliense porins
A and B. In addition, the genomes of Mmas CIP108297
and Mabs ATCC 19977 encode a third, more distantly
related, porin gene (MAB_2800 in Mabs ATCC 19977)
which we renamed mmpC and six other proteins sharing
22–53% identity with MmpC annotated as putative porins
(MAB_2799; MAB_1321; MAB_3154c; MAB_2329c; MAB_0734
and MAB_1891). The mature MmpA and MmpB porin products
share 97% identity between them and 72–73% identity with
MspA from M. smegmatis (Supplementary Figure 1) (98.9–
100% identity with the Mabs ATCC 19977 porin products,
MAB_1080 and MAB_1081). MmpC shares only 22% identity
(27.8% similarity) with MmpA and MmpB from Mabs ATCC
19977 and 22.3% identity (28.4% similarity) with MspA
from M. smegmatis mc2155. 463 bp of nucleotide sequence
separate mmpA from mmpB in Mmas CIP108297 and Mabs
ATCC 19977 suggesting that the two genes are probably
each monocistronic.
Variation in Genome Organization at the
Porin Locus of MABSC Clinical Isolates
At least one (mmpA/mmpB- or mmpC-like) porin gene homolog
was detected in all the MABSC genomes used in this study
(n = 1,382). However, analysis of the depth of coverage of the
mapped reads over the mmpA and mmpB porin loci of the 1,382
MABSC genomes used herein showed that there was variation
in the number of porin genes encoded at this position. Overall,
1,059 isolates encoded both mmpA and mmpB porin genes at this
locus, 312 isolates encoded a single mmp-like porin gene (a fusion
of mmpA and mmpB; see further) and 11 isolates encoded no
mmp-like porin genes at this locus.
Of the 526 isolates associated with pulmonary infections,
469 isolates encoded two mmp-like porin genes at this locus
(Figure 1A), 54 encoded a single mmp-like porin fusion gene
(Figure 1B) and three isolates encoded no mmp-like porin genes
at this locus (Figure 1C). A single mmp-like porin gene, a
fusion of mmpA and mmpB, was observed in 180 of 189 isolates
associated with the post-surgical wound infection epidemic in
Brazil (Duarte et al., 2009; Leao et al., 2010; Everall et al., 2017),
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FIGURE 1 | Nucleotide BLAST comparisons between the mmpA/mmpB porin locus of Mabs ATCC 19977 and isolates that encode the variants observed in the
porin locus both across the global population and longitudinally. The gray bars illustrate the various rearrangements [or no rearrangement in the case of (A)]
observed in clinical isolates and are color-coded to indicate the percentage identity of the genomic sequences of the two isolates that are being compared. (A) Is an
example of when mmpA and mmpB are both present. (B) Is an example of the fusion of mmpA and mmpB, resulting in a single mmp-like gene. (C) Is an example of
the complete deletion of both mmp-like porin genes at the porin locus. Porin genes are colored in blue and yellow.
while the remaining 9 isolates encoded two mmp-like porin
genes at this locus.
Short indels, leading to the loss of function of the protein, were
observed in mmpA in seven isolates associated with pulmonary
infections. One isolate incurred a non-synonymous mutation
resulting in a premature stop codon, W220∗.
Changes in genome organization at the mmpA/mmpB locus
were also observed in isolates collected from the same patient
over time. Isolates from 15 of the 190 CF patients for which
longitudinal samples were available were found to vary in the
number of mmp-like porin genes encoded by this locus. Isolates
from 12 of the 15 patients either encoded one or two mmp-like
porins, one patient’s isolates encoded either two mmp-like porin
genes or no mmp-like porin genes, one patient’s isolates encoded
either one mmp-like porin gene or no mmp-like porin genes and
the final patient’s isolates varied between encoding either two, one
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FIGURE 2 | Maximum likelihood phylogeny of the MABSC global population. The global population shown here consist of 526 isolates associated with pulmonary
infections and 188 isolates associated with the epidemic of post-surgical wound infections in Brazil. The metadata aligned shows, for each isolate, the country of
isolation, the predicted composition of the porin locus and the isolates for which the fusion position was predicted. The scale bar on the phylogeny represents the
number of substitutions per variable site.
or no mmp-like porin genes at the mmpA/mmpB locus. A further
four patients’ isolates were shown to have accumulated indels in
mmpA over time. No non-synonymous mutations were found to
have occurred within patients over time.
As noted above, where isolates were found to have only
one mmp-like porin gene at the mmpA/mmpB porin locus, a
recombination event had occurred leading to the fusion of mmpA
and mmpB. We examined the sequences of the 312 predicted
mmpA/mmpB fusion genes to determine where in the sequence
the fusion occurred. Of the 312 predicted mmpA/mmpB fusion
genes, it was only possible to extract the complete sequence of
the gene from the draft assembly of 297 isolates. It was possible
to predict the fusion position for 38 of these isolates, with six
unique fusion positions predicted which spanned close to the
entire length of mmpA (Figure 2). All six fusion positions were
also seen in isolates where changes in the number of mmp-
like porin genes encoded at the mmpA/mmpB porin locus were
observed over time within a patient. All the predicted fusion
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positions fall after the signal peptide sequence at the N-terminal
of MmpA and, therefore, all the fusion genes use the signal
peptide sequence of this porin.
Generation of mmpA and mmpB
Knock-Out Mutants of Mmas
Because the changes occurring at mmpA/mmpB loci of
longitudinally isolated strains from CF patients was suggestive
of the involvement of MmpA and MmpB in the adaptation
of MABSC to the host, subsequent studies were undertaken to
determine whether these naturally occurring mutations arose as
a result of the selective pressure of antibiotic treatment or as part
of a more general adaptation of the bacterium to stresses imposed
by the host environment.
To investigate the role of MmpA and MmpB in the physiology
and virulence of MABSC, we first sought to knock-out each of
these two porin genes of Mmas CIP108297 by allelic replacement.
To this end, the recombineering method was used wherein
Mmas CIP108297 expressing the Gp60 and Gp61 recombineering
proteins from mycobacteriophage Che9c from pJV53-XylE (van
Kessel and Hatfull, 2007; van Kessel et al., 2008; Calado Nogueira
de Moura et al., 2014) was electrotransformed with linear allelic
exchange substrates designed to replace the entire mmpA or
mmpB loci with a streptomycin-resistance cassette. Twelve to
55 double crossover candidates were selected for each gene and
analyzed by PCR. PCR analysis confirmed that allelic replacement
had occurred in 18% of the mmpA candidate mutants and 50%
of the mmpB candidate mutants (Figure 3A). Two passages in
liquid broth devoid of Kan followed by plating on Str-containing
agar yielded single mmpA and mmpB mutant clones devoid of
pJV53-XylE plasmid. In contrast, three independent attempts to
inactivate both porin genes simultaneously yielded no double
crossover mutant suggesting that, similar to the situation in
M. smegmatis (Stephan et al., 2005), the presence of at least one
functional porin gene is required for Mmas CIP108297 growth
under the experimental conditions used herein. Given that our
genomic analysis identified 11 isolates devoid of mmpA and
mmpB genes, one may only speculate that the mmpC gene and
homologs present in these isolates can compensate for the lack
of mmpA and mmpB in a way that is not achievable in Mmas
CIP108297.
Impact of mmpA and mmpB Deficiency
on Porin Production and Activity
Porin production in the mutant strains was analyzed by
Western blot using polyclonal antibodies to the MspA porin
of M. smegmatis (Stahl et al., 2001). While porin products of
the expected size (19.6 kDa) were detected in the wild-type
(WT) Mmas CIP108297 strain, they were barely detectable in the
mmpA knock-out; the intensity of the porin signal in this mutant
was only about 6–10% of that detected in the WT parent. In
comparison, the intensity of the band was decreased by less than
40–50% in the mmpB knock-out (Figure 3B). Complementation
of the mutants with their respective porin gene or with both porin
genes expressed from the replicative multicopy plasmid pOMK
increased porin production in the mmpA knock-out relative to
the WT parent 3.4- and 5-fold, respectively, and that in the mmpB
knock-out mutant 1- and 10-fold, respectively.
Porin expression in the two mutants was further analyzed by
qRT-PCR to check for a potential polar effect of the inactivation
of mmpA on the expression of mmpB and for the existence of
compensatory mechanisms regulating the level of expression of
the two porin genes. The result of two independent experiments
indicated that while the level of expression of mmpA was only
about 1.3–2-fold less in the mmpB mutant relative to the WT
strain, the expression of mmpB increased 4–7-fold in the mmpA
knock-out (Figure 3C). qRT-PCR analysis further revealed that
the level of expression of mmpA relative to sigA was > 14-fold
greater than that of mmpB in WT Mmas CIP108297, thereby
confirming MmpA as the major porin product of this isolate and
explaining the more dramatic effect of knocking-out mmpA over
mmpB on the total porin content of this strain (Figure 3B).
As expected, the disruption of mmpA impacted more
dramatically the growth rate of Mmas CIP108297 than that
of mmpB, the latter mutant growing at a similar rate as its
WT parent in minimal GAS (Glycerol-Alanine-Salts) medium
(Figure 4A) and at an intermediate rate between the mmpA
knock-out and the WT strain in glucose-based medium
(Figure 4B). Complementation with the individual or combined
mmpA and mmpB genes restored WT growth in the mutants
(Figures 4A,B).
Consistent with these observations, the mmpA knock-out
mutant presented a significantly reduced [14C]-glucose uptake
rate relative to the WT parent (8.75 ± 0.03 vs. 17.11 ± 0.47
pmoles of glucose/mg cells/min) which was restored to WT
levels upon complementation with mmpA (17.86 ± 0.41
pmoles of glucose/mg cells/min), and beyond WT levels upon
complementation with mmpA and mmpB (23.35 ± 1.67 pmoles
of glucose/mg cells/min) (Figure 5). The mmpB knock-out
mutant, in contrast, was as proficient at taking up [14C]-glucose
as WT Mmas CIP108297 in this assay (16.23 ± 0.58 and
17.11 ± 0.47 pmoles of glucose/mg cells/min, respectively).
Susceptibility of the Mmas Porin
Knock-Out Mutants to Glutaraldehyde,
Antibiotics, and Nitrosative Stress
Because of the reported impact of porins on the susceptibility
of M. smegmatis and M. chelonae to biocides and nitrosative
stress (Fabrino et al., 2009; Svetlikova et al., 2009; Frenzel et al.,
2011), we next set out to test the resistance of the mmpA and
mmpB knock-out mutants to a number of stresses including
various classes of antibiotics used in the clinical treatment of
fast-growing mycobacterial infections, the high-level disinfectant
glutaraldehyde (GTA), and nitric oxide (NO). Apart from a
modest 2–4-fold increase in the resistance of the mmpA knock-
out mutant to ciprofloxacin and imipenem, the two mutants
presented susceptibility patterns to antibiotics (Table 1) and GTA
(Supplementary Figure 2) comparable to those of their WT
parent. In particular, both mutants displayed WT susceptibilities
to drugs used in the clinical treatment of MABSC infections
such as clarithromycin, erythromycin, azithromycin, amikacin,
cefoxitin, linezolid and tigecycline. The mmpA and mmpB
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FIGURE 3 | Gene replacement at the mmpA and mmpB porin loci of Mmas. (A) Porin gene cluster of Mmas CIP108297. The positions of the primers used to
generate the allelic exchange substrates and analyze the candidate mutants are indicated along with the expected sizes of the PCR fragments. Candidate mmpA
and mmpB mutants were analyzed by PCR using different sets of primers, including Mpt-Rv/MscL-Fw located outside the allelic exchange substrates, MMPorin1
Fw/MMPorin1 Rv, and MMPorin2 Fw/MMPorin2 Rv (see Supplementary Table 1). MWM, molecular weight marker; IGR, intergenic region. (B) Immunoblot analysis
of porin production in the WT, mutant and complemented mutant strains. Strains were grown in 7H9-OADC-Tween 80 broth at 30◦C to mid-log phase (OD600 = 1)
and porins were selectively extracted from whole cells at 100◦C using 0.5% n-octylpolyoxyethylene as a detergent as described (Heinz et al., 2003). Protein samples
prepared from the same amount of cells for each strain were denatured by boiling in 80% DMSO followed by acetone precipitation (Heinz et al., 2003). Denatured
proteins were loaded volume to volume, separated by SDS-PAGE, blotted onto a nitrocellulose membrane, and porins were detected using rabbit antiserum to
purified MspA (Stahl et al., 2001). Immune complexes were detected by chemiluminescence (Pierce, ELC) and semi-quantified using the Image Lab software
(Biorad). The expected size of the mature MmpA and MmpB porins is 19.65 kDa. (C) mmpA and mmpB mRNA levels in the WT, mutant and pOMK complemented
mutant strains. The target cDNA was normalized internally to the sigA cDNA in the same sample. Ratios of mmpA/sigA or mmpB/sigA mRNA are means ± standard
deviations (n = 3 qRT-PCR reactions). RNA extractions and qRT-PCR experiments were performed twice using independent culture batches and the results of one
representative experiment are shown.
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FIGURE 4 | Growth rates of wild-type Mmas, its isogenic mmpA and mmpB
knock-out mutants and the complemented porin mutants in GAS-tyloxapol (A)
and glucose-based medium (B) at 37◦C. Shown are representative results of
two independent experiments. The glucose-based minimal medium consists
of 20 mM asparagine, 1.5 mM KH2PO4, 0.75 mM Na2HPO4, 50 µM FeCl3,
1.6 mM MgSO4, 4.5 micromolar CaCl2, 3.5 µM ZnSO4, 0.59 micromolar
MnSO4, 10 mM glucose and 0.05% tyloxapol in 50 mM MOPS (pH 7.0).
knock-outs further displayed WT susceptibility to NO in vitro
(Supplementary Figure 3).
Growth of Mmas Porin Mutants in SCID
and GMCSF Knock-Out Mouse Bone
Marrow-Derived Macrophages (BMDM)
We investigated the capacity of Mmas reference strain CIP108297
and corresponding porin knock-out mutants to replicate and
persist in BMDM to evaluate their virulence. The growth
of each strain was determined in BMDM prepared from
SCID and GMCSF knock-out mice by the method of plating
to measure colony-forming units (CFU) over a period of
6 days. While no significant difference in bacterial uptake was
noted between strains, both mutants demonstrated significantly
increased replication in SCID (Figure 6A) and GMCSF knock-
out (Figure 6B) BMDM compared to their WT parent, with the
mmpB mutant consistently displaying the most acute virulence
phenotype of the two. Throughout the experiment, BMDM
cellular viability (as assessed by the percentage of propidium
iodide positive dead cells) was above 95% and similar for all
strains indicating that the porin mutants were not more cytotoxic
than their WT parent in these macrophage models (data not
shown). The replication of the mutants in macrophages was
restored to or below WT levels upon genetic complementation
with both porin genes (Figure 6B), and between WT and knock-
out levels upon complementation with the individual WT copy of
mmpA or mmpB (Figures 6A,B).
Pathogenicity of the Porin Knock-Out
Mutants in SCID Mice
We used a SCID mouse intravenous infection model to compare
the virulence of Mmas WT, mutant and complemented mutant
strains in vivo. The rationale for using this immunocompromised
mouse model is related to the difficulty of establishing a high-
level pulmonary infection with rapidly growing mycobacteria
in immunocompetent mice (Obregon-Henao et al., 2015).
Moreover, this model more closely reflects an infection which
would occur in immunocompromised patients, a population
particularly at risk for NTM infections (Chan et al., 2010; Prevots
and Marras, 2015). Following intravenous infection, the bacterial
loads in the lung, spleen and liver were quantified on days 1
and 15 post-infection. Consistent with the observations made in
infected BMDM, infection with the mmpA and mmpB knock-out
mutants resulted in increased bacterial loads in the lungs, spleen
and liver at 15 days relative to the infection with the WT parent
strain, with the mmpB mutant displaying the most dramatic
increase in virulence (Figure 7). Virulence was restored to or
below WT levels upon genetic complementation of the mmpB
mutant with both porin genes, and that of the mmpA mutant with
a WT copy of mmpA. The mmpB mutant complemented with
both porin genes was used in this in vivo study because of the
limited impact of complementing this mutant with mmpB only
in murine macrophages (i.e., replication rate significantly above
that of the WT parent strain) (Figures 6A,B).
Lung histopathology mirrored these observations in that more
severe peribronchiolar inflammatory infiltrates and increased
cellular foci with early granuloma formation were observed in the
lung tissues of the animals infected with the mmpB knock-out
strain (Figure 8C). In comparison, mice infected with the WT
parent and the complemented mutant strains displayed similar
lung histopathology with less inflammatory foci and pulmonary
involvement, and more healthy lung tissue (Figures 8A,D,E). The
mmpA mutant displayed an intermediate phenotype (Figure 8B).
DISCUSSION
The results of our combined genomic and genetic studies indicate
that MABSC isolates generally harbor one or two Msp-like porins
at the mmpA/mmpB locus and that MmpA is the predominant
one in terms of level of expression and contribution to nutrient
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FIGURE 5 | Glucose uptake by wild-type Mmas, the mmpA and mmpB knock-out mutants and the complemented porin mutant strains. The accumulation of
[U-14C]glucose by the strains over time was measured as described (Calado Nogueira de Moura et al., 2014). Glucose uptake was measured in duplicate samples
and the average values are shown with their standard deviations. Glucose uptake rates were calculated on the first 120 min of the reactions.
TABLE 1 | Susceptibility of the Mmas porin mutants to antibiotics.
Strains AMI APR AZI CIP CLA ERY TET KAN CEF IMI TIG LIN
Mmas CIP108297 16–32 2 1–2 32–64 0.25 8–16 32 8 64 32 2–4 16
Mmas1mmpA 32 2–4 1–2 128 0.5 8 8 8 64 64–128 4 16
Mmas1mmpB 16–64 4 2 32–64 0.5 16 16 8 64 32 4 16
Mmas1mmpA/pOMK-mmpA 64 2 2 32 1 32 8 nd 64 64 4 16
Mmas1mmpA/pOMK-mmpAB 32 4 4 32 1 16 16 nd 64 64 4 16
Mmas1mmpB/pOMK-mmpB 32 4 2 32 0.25 8 8 nd 64 32 2–4 16
Mmas1mmpB/pOMK-mmpAB 32 4 2 32 0.5 8 8 nd 64 32 4 16
MIC were determined in Mueller-Hinton II broth and MIC values are in µg/ml.
AMI, amikacin; APR, apramycin; AZI, azithromycin; CEF, cefoxitin; CIP, ciprofloxacin; CLA, clarithromycin; ERY, erythromycin; IMI, imipenem; KAN, kanamycin; LIN,
linezolid; TET, tetracycline; TIG, tigecycline. MIC determinations were performed two to three times on independent culture batches. nd, not determined.
uptake (as measured by [14C]-glucose uptake) when both porins
are present. The disruption of mmpA had a moderate effect on
growth in GAS medium and a more marked effect on growth
in glucose-based medium. Neither the disruption of mmpA or
mmpB had any significant effect on the antibiotic susceptibility
profile of Mmas CIP108297. Likewise, neither mutant showed
increased resistance to GTA in vitro. The latter result and
the fact that prototypical GTA-resistant outbreak isolates from
Brazil (CRM-019 and CRM-020) have two porins identical in
sequence to those of the GTA-susceptible isolates CRM-0270
and CIP108297 (Supplementary Figure 4; Duarte et al., 2009;
Davidson et al., 2013) suggest that Msp-type porins have no
involvement in the high-level GTA resistance phenotype of the
Brazilian outbreak isolates, in contrast to the situation in GTA-
resistant M. smegmatis and M. chelonae laboratory strains and
clinical isolates described earlier (Svetlikova et al., 2009).
The significant increase in virulence of the mmpA and mmpB
knock-out mutants in murine macrophages and in SCID mice
indicates that the primary impact of alterations in surface porin
expression may be on the interactions of MABSC with the
host as has been reported in a number of pathogenic bacteria
(Achouak et al., 2001; Skurnik et al., 2013; Geisinger and Isberg,
2017; Lee et al., 2017). The fact that the mmpB knock-out
displays the greatest intracellular replication rate and increase in
pathogenicity of the two mutants, yet is the one whose ability to
import glucose is the least affected, indicates that this increase
in virulence is independent from channel activity and, instead,
points to the differential impact of expressing surface MmpB vs.
surface MmpA on MABSC’s interactions with the host.
The increased virulence of the mmpB and mmpA mutants
did not correlate with increased uptake by macrophages,
cytotoxicity toward infected macrophages or enhanced resistance
to nitrosative stress suggestive of the involvement of other
virulence mechanisms whose determination will be the object
of future studies. Based on what is known of the roles
of porins in the virulence of other bacterial pathogens,
including CF pathogens, other contributing factors may include
decreased susceptibility of the Mmas porin mutants to killing
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FIGURE 6 | Increased intracellular replication of the porin mutants in SCID
and GMCSF knock-out mouse bone marrow-derived macrophages. (A)
Intracellular growth of the WT and mutant strains in SCID BMDM. BMDM were
infected with Mmas strains at a MOI of 1:1. Viable intracellular bacteria were
determined by CFU counting after 2 h of infection or at 1, 2, 3 and 6 days after
infection. Values shown are the mean ± SEM from three infected macrophage
monolayers. (B) Intracellular growth of the WT, mutant and complemented
mutant strains in GMCSF BMDM. BMDM were infected with Mmas strains at
a MOI of 1:1. Viable intracellular bacteria were determined by CFU counting
after 2 h of infection or at 1, 2, 4, and 6 days after infection. Values shown are
the mean ± SEM from three infected macrophage monolayers. Asterisks
denote statistical differences between the growth of the knock-out mutants (or
the mmpB KO complemented with mmpB only) and the WT parent strain
pursuant to the Student’s t-test (*P < 0.05; **P < 0.01; ***P < 0.005).
by antimicrobial peptides and other host-derived bactericidal
compounds, altered interactions with components of the
complement cascades, and alterations in their interactions with
other cell types than macrophages not analyzed herein (e.g.,
epithelial cells) (Achouak et al., 2001; Sharbati-Tehrani et al.,
2005; Fabrino et al., 2009; Purdy et al., 2009; Skurnik et al., 2013;
Lee et al., 2017). Potential changes in the transcription of other, as
yet unidentified, genes resulting from the loss of porin expression
as reported in carbapenem-resistant Pseudomonas aeruginosa
oprD mutants (Skurnik et al., 2013), could further contribute to
these virulence-associated phenotypic changes.
Consistent with porin content playing a role in the ability
of MABSC to evade the host’s defenses, we observed significant
FIGURE 7 | Increased bacterial load in the lungs, spleens and livers of SCID
mice infected with the Mmas porin knock-out strains. Bacterial counts in the
lungs (A), spleens (B) and livers (C) on days 1 and 15 from SCID mice
intravenously infected the WT, porin mutant and complemented mutant
strains. Results are expressed as the average (n = 5) of the bacterial load in
each group expressed as Log10 CFU ± standard error mean (SEM). Growth
of the two porin knock-out mutants was significantly higher than that of the
WT parent strain pursuant to the Student’s t-test (*P < 0.0005;
**P < 0.00005; ***P < 0.000005).
DNA rearrangements affecting the mmpA/mmpB locus of some
of the 1,382 MABSC clinical isolates analyzed in this study. That
these DNA rearrangements reflect an attempt of these isolates
to overcome antibiotic treatment is unlikely given the lack of
significant changes in the antibiotic susceptibility profile of Mmas
CIP108297 following the disruption of mmpA or mmpB.
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FIGURE 8 | Increased pulmonary pathology in the lungs of SCID mice infected with the mmpB knock-out. (A–E) Show representative photomicrographs of
hematoxylin and eosin- and acid-fast bacilli-stained slides from the lungs of SCID mice intravenously infected with Mmas CIP108297 (A), the mmpA mutant (B), the
mmpB mutant (C), the mmpA mutant complemented with mmpA (D) and the mmpB mutant complemented with mmpA + mmpB (E). As early as 15 days after
infection, increased granulomatous lesions and thickening of the interstitium indicative of increased inflammation were observed in mmpB-infected mice and, to a
lesser extent in mmpA-infected mice, compared to the other groups. Magnification (– 1x, – 10x and —100x magnification).
The predominant changes observed longitudinally within CF
patients were changes in the number of mmpA/mmpB porin
genes. However, where short indels were observed longitudinally,
they were all found to occur in mmpA, which could suggest that
the phenotypic effects of the mmpA knock-out are specifically
under selection in the context of adaption to the CF lung
environment. The impact on virulence of fusing the mmpA
and mmpB genes observed in a number of clinical isolates is
impossible to predict without dedicated experimentation but is
expected to vary with the point of fusion since early fusion
points will result in strains expressing mostly an MmpB-type
porin and late fusion point will result, on the contrary, in
strains expressing mostly a MmpA-like porin. With the data
available, we found no evidence to suggest that a particular
mmpA/mmpB fusion was being selected for, neither within
our global collection of MABSC isolates nor in within-patient
longitudinal isolates. Finally, we found no evidence that the porin
locus was playing a role in the adaptation of clustered MABSC
lineages to increased virulence or transmission as we observed
no significant association between the number of mmp-like porin
genes encoded at the mmpA/mmpB porin locus and whether
an isolate had been classified as clustered or unclustered (data
not shown) (Bryant et al., 2016). However, 60% of the isolates
that encoded only one mmpA/mmpB porin gene (discounting
the isolates from Brazil as these are all associated with a single
outbreak), occurred in just three of the clusters defined by Bryant
et al. (2016, Figure 2), which suggests that, whilst porin genes
may not be playing a role in the increased virulence/transmission
of all clustered isolates, they could be contributing to the
adaptation of particular lineages.
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